Replies to post #89591 on Anavex Life Sciences Corp (AVXL)

[tradeherpete]

stealthways,
I don’t have the understanding chemically of what A2-73 is or how it works but am excited to know what it can do.

That A2-73 can get the brain, of all organs, to function properly, all kinds of ideas start popping in my head about what might be possible. An all access pass to the ER is pretty cool and I guess we’re finding it can compete there with donepezil as well.

How enzymes interact with the proteins and amino acids is beyond me and you would be wasting your time trying to explain it. I’m happy to read and try to follow the smoke.

I like the chances of 273 (and the 273 metabolite and 371 (remember thats 3 separate similar Sigma 1 agonists)) acting to both reduce pain and improve sleep problems .... so thats both a PAIN and SLEEP DISORDER drug pipeline.... this is very large in itself but separate from (the much larger) platform potential for both multiple disease vaccine and multiple disease treatment ....

****Remember 273 is very rare in that its metabolite acts on the same two main receptors that the initial active ingredient does....

Just saying that; Pain and Sleep disorder drug pipeline, if it works could relieve so much suffering. Hard to imagine it can happen without opioids or depressants. If it can cure the underlying disorders and provide relief it will mark a departure from the band aid approach we call medicine. We’re looking at the monolith from 2001. Exciting stuff.

imo